MoneyWorks4Me

Pharmaids Pharmaceuticals informs about outcome of board meeting

01 Jul 2026 Evaluate

Pursuant Regulation 30 read with Schedule III of Listing Regulations, Pharmaids Pharmaceuticals has informed that the Board of Directors of the Company at their meeting held on Tuesday, June 30, 2026, have, basis recommendation of the Audit Committee, considered and approved the appointment of V Mahendra & Associates Chartered Accountants (FRN: 025356S) as Internal Auditors of the Company for carrying out the Internal Audit for the financial year 2026-27. The disclosure as required under Regulation 30 of the Listing Regulations read with SEBI Master Circular dated January 30, 2026, is enclosed as Annexure A. The above Information is being made available on the Company’s website: www.pharmaids.com.

The above information is a part of company’s filings submitted to BSE.


Peers
Company Name CMP
Sun Pharma. Inds. 1842.00
Dr. Reddys Labs. 1161.00
Cipla 1365.00
Lupin 2096.00
Zydus Lifesciences 1119.50
View more..